International product information

The product details shown after you switch describe the versions of Rho authorized outside the United States, including the Rho Score, which is not part of the US version.

US product information

The product details shown after you switch describe the version of Rho authorized in the United States, which reports whether a patient is Rho Positive.

Request a demo →
← All news
Research

Prospective Sunnybrook study published: Rho findings reported in 80% of cases

Toronto. The Canadian Association of Radiologists Journal published Sunnybrook's prospective study of Rho: 655 of 987 screened patients were flagged, radiologists reported 80% of findings, and Rho-positive patients more often reported discussing bone health with their doctor (36% vs 18%) and a new osteoporosis diagnosis (11% vs 5%) within six months than Rho-negative patients.

The study, led by Sunnybrook’s Department of Medical Imaging, enrolled 1,145 patients having routine X-rays, of whom 987 had an X-ray Rho could analyze. Among flagged patients who had a DXA within six months, Rho’s positive predictive value for low bone density was 74%. Of 51 primary care providers who answered the survey, 78% found Rho beneficial in patient care.

The authors concluded that Rho has the potential to improve low osteoporosis screening rates by using existing X-ray data.